Three Different Techniques for Tracheal Intubation Via Supraglottic Airway Devices

Sponsor
University Hospital of Patras (Other)
Overall Status
Recruiting
CT.gov ID
NCT04346459
Collaborator
(none)
120
1
3
34.7
3.5

Study Details

Study Description

Brief Summary

This study compares three different supraglottic airway devices used as a conduit for tracheal intubation in order το determine which one achieves the highest success rate of first attempt intubation

Condition or Disease Intervention/Treatment Phase
  • Procedure: Tracheal intubation through "Fastrach" - Group A
  • Procedure: Tracheal intubation through "I-gel" - Group B
  • Procedure: Tracheal intubation through "Protector" - Group C
N/A

Detailed Description

Prospective, randomized, comparative, clinical, controlled study, that is approved by the Ethics Commitee of the University of Patras (10.12.2019) and takes part in the University Hospital of Patras. Depending on the supraglottic airway device (SGA)/ laryngeal mask airway (LMA) used to achieve intubation (Fastrach, I-gel, Protector), partcipants will be randomly allocated into three groups; Group A, B and C (Fastrach, I-gel, Protector respectively).

In the preoperative setting, a complete preanesthetic evaluation will be performed, including a detailed airway assessment (prediction of difficulty in face mask ventilation, insertion of SGA/LMA and intubation).

All patients are scheduled to undergo an elective surgery under general anesthesia. Before induction, all patients will be preoxygenated with FiO2 100% for at least 5 minutes. After induction, using rocuronium 0.6mg/kg to facilitate neuromuscular blockade, face mask ventilation follows.

  1. Group A- Fastrach: The intubating laryngeal mask airway (Fastrach) will be placed to the patients of this group. After the mask is correctly placed and patients are adequately ventilated, they will be intubated through the mask using its own endotracheal tube according to the blind technique insertion.

  2. Group B- I-gel: The supraglottic airway device (I-gel) will be placed to the patients of this group. After the mask is correctly placed and patients are adequately ventilated, they will be intubated through the mask using a fiberoptic bronchoscope to guide endotracheal tube's placement.

  3. Group C- Protector: The supraglottic airway device (Protector) will be placed to the patients of this group. After the mask is correctly placed and patients are adequately ventilated, they will be intubated through the mask using a fiberoptic bronchoscope to guide endotracheal tube's placement.

In all groups (A, B, C) up to 3 attempts of SGA/LMA placement and up to 3 attempts of intubation are allowed to be made.

In case of an emerging unpredicted difficult airway and a concurrent unsuccessful SGA/LMA placement, then the algorithm of the difficult airway will be immediately followed. Video-assisted laryngoscopy will be the first option rescue alternative.

The time of the whole procedure from the beginning of SGA's/LMA's placement effort until the successful intubation will be recorded, along with the evaluation of the success rate of first intubation attempt.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of Three Different Techniques for Tracheal Intubation Via Supraglottic Airway Devices: A Comparative Randomised Study
Actual Study Start Date :
Jan 10, 2020
Anticipated Primary Completion Date :
Mar 30, 2022
Anticipated Study Completion Date :
Nov 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group A- Fastrach (control group)

Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using intubating laryngeal mask airway "Fastrach" following blind intubating method through "Fastrach"

Procedure: Tracheal intubation through "Fastrach" - Group A
Insertion of the intubating laryngeal mask "Fastrach" and blind tracheal intubation through the device

Active Comparator: Group B- I-gel

Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using "I-gel" supraglottic airway device as a conduit for tracheal intubation guided by a fiberoptic bronchoscope.

Procedure: Tracheal intubation through "I-gel" - Group B
Insertion of the supraglottic airway device "i-gel" and tracheal intubation through the device guided by a fiberoptic bronchoscope

Active Comparator: Group C- Protector

Group of 40 patients scheduled for elective surgery under general anesthesia are planned to be intubated using the "Protector" laryngeal mask airway as a conduit for tracheal intubation guided by a fiberoptic bronchoscope.

Procedure: Tracheal intubation through "Protector" - Group C
Insertion of the laryngeal mask "Protector" and tracheal intubation through the device guided by a fiberoptic bronchoscope

Outcome Measures

Primary Outcome Measures

  1. Success rate of intubation at first attempt [Up to study completion, an average of 2 years]

    Recording of successful tracheal intubation at first attempt (yes/no) and evaluation of the success rate at first attempt

Secondary Outcome Measures

  1. Time required for tracheal intubation [Up to study completion, an average of 2 years]

    Time required from the beginning of the insertion of the supraglottic airway device/ laryngeal mask until the endotracheal tube is successfully placed confirmed by continuous waveform capnography (3 cycles)

  2. Time required for successful supraglottic airway device/ laryngeal mask placement [Up to study completion, an average of 2 years]

    Time required from the beginning of the insertion of the supraglottic airway device/ laryngeal mask until adequate ventilation is confirmed by continuous waveform capnography (3 cycles)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients (age ≥ 18 yrs) scheduled for an elective surgery under general anesthesia

  • Written informed consent to participate in the trial

Exclusion Criteria:
  • Age < 18 yrs

  • Non- elective (urgent/ emergency) procedures or multi-trauma patients

  • Obstetric population

  • Surgery performed under regional anesthesia

  • Contraindication to LMA insertion

  • Predicted difficulty in LMA insertion (at least one out of four "RODS" criteria)

  • Contraindication to the use of neuromuscular blockade or situations that require spontaneous breathing

  • Indication for awake intubation or surgical airway

  • Patients' involvement in another clinical trial

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital of Patras Patras Achaia Greece 26500

Sponsors and Collaborators

  • University Hospital of Patras

Investigators

  • Study Chair: Gregorios Voyagis, MD, PhD, University of Patras, Department of Anesthesiology and Critical Care

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maria Spyraki, Principal Investigator, University Hospital of Patras
ClinicalTrials.gov Identifier:
NCT04346459
Other Study ID Numbers:
  • 11/11/2019anesthesia
First Posted:
Apr 15, 2020
Last Update Posted:
Jan 19, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Maria Spyraki, Principal Investigator, University Hospital of Patras

Study Results

No Results Posted as of Jan 19, 2022